PIN20 THE IMPACT OF COST-EFFECTIVENESS OF COUNTRY SPECIFIC APPLICATION—THE CASE OF DROTRECOGIN ALFA (ACTIVATED) IN SEVERE SEPSIS

Authors :: A Davies
Ulf Persson
Jonas Hjelmgren
G. Ragnarson Tennvall
Source :: Value in Health. (6):752-753
Publisher :: International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.

Subjects :: medicine.medical_specialty
business.industry
Cost effectiveness
Drotrecogin alfa
Health Policy
medicine
Public Health, Environmental and Occupational Health
Intensive care medicine
business
Severe sepsis
medicine.drug

Full Text Access

Tools